Molnupiravir: Merck's Covid-19 antiviral less effective in new analysis - Pharmaceutical Technology
Molnupiravir: long-term safety questions linger as approvals approach - Pharmaceutical Technology
Merck | Home
Merck in Deal With Sinopharm to Bring Covid Antiviral Molnupiravir to China - Bloomberg
Canada enters deals to procure Merck and Pfizer's Covid-19 antiviral pills
Study: Merck's COVID-19 drug reduces hospitalization risk | Coronavirus | wkow.com
Merck Keeps Striking Out on Expanding Its Cancer-Drug Juggernaut - WSJ
Merck Issues Voluntary Nationwide Recall of CUBICIN® (daptomycin for injection) 500 mg, Lot 934778, Due to Presence of Particulate Matter Identified as Glass Particles - Merck.com
Merck and Ridgeback begin Phase III trial of molnupiravir for Covid-19
Merck & Co Manufacturing Mishap Leads to Carcinogen in Diabetes Medication
Merck's Molnupiravir: Second COVID Pill Is Second-Line, But Timing Helps Both Sponsor And US FDA :: Pink Sheet
Merck Pill Intended to Treat Covid-19 Succeeds in Key Study - WSJ
Merck's Covid-19 Pill Heavily Used So Far Despite Concerns - WSJ
Merck Says Its Covid Pill Is Less Effective in a Final Analysis - The New York Times
Merck to share license for COVID-19 pill with other drugmakers to expand access
Merck signs deal to supply Singapore with its Covid-19 antiviral pill
Merck struggles to win European approval for Covid antiviral pill | Financial Times
FDA authorizes Merck's Covid-19 pill, but stresses its use should be limited
With UK nod, Merck drug becomes world's 1st pill for Covid treatment - The Economic Times
Pfizer COVID pill approved in Japan, following Merck treatment - Nikkei Asia
Merck's (MRK) Covid Drug Linked to Viable, Spreading Mutants, Study Says - Bloomberg
U.S. allows Merck's COVID-19 pill amid safety, variant concerns | Science | AAAS
Legavrio COVID-19 Pill by Merck Continues Its Slump | Fierce Pharma
Merck: Experimental Pill Treats COVID-19 at Earliest Stages | St Vincents Medical Center
Merck signs $1.2 billion deal with US government for experimental COVID treatment - ABC News
Emory supports Medicines Patent Pool and Merck license agreement for molnupiravir to treat COVID-19
